Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

colgate-palmolive co. - CL

CL

Close Chg Chg %
93.89 0.35 0.37%

Closed Market

94.24

+0.35 (0.37%)

Volume: 3.64M

Last Updated:

Nov 21, 2024, 3:59 PM EDT

Trade Now

Company Overview: colgate-palmolive co. - CL

CL Key Data

Open

$94.03

 Day Range

93.30 - 94.92

52 Week Range

75.50 - 109.29

 Market Cap

$76.73B

Shares Outstanding

817.01M

 Public Float

816.03M

Beta

0.41

 Rev. Per Employee

N/A

P/E Ratio

26.98

 EPS

$3.50

Yield

210.84%

 Dividend

$0.50

EX-DIVIDEND DATE

Oct 18, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

4.88M

  

CL Performance

1 Week
 
 0.74%
 
1 Month
 
 -1.42%
 
3 Months
 
 -9.56%
 
1 Year
 
 21.91%
 
5 Years
 
 41.28%
 

CL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 25
Full Ratings ➔

About colgate-palmolive co. - CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

CL At a Glance

Colgate-Palmolive Co.
300 Park Avenue
New York, New York 10022-7499
Phone 1-212-310-2000 Revenue 19.46B
Industry Household/Personal Care Net Income 2.30B
Sector Consumer Non-Durables 2023 Sales Growth 8.293%
Fiscal Year-end 12 / 2024 Employees 34,000
View SEC Filings

CL Valuation

P/E Current 26.98
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 28.737
Price to Sales Ratio 3.397
Price to Book Ratio 107.511
Price to Cash Flow Ratio 17.649
Enterprise Value to EBITDA 15.829
Enterprise Value to Sales 3.822
Total Debt to Enterprise Value 0.122

CL Efficiency

Revenue/Employee 572,264.706
Income Per Employee 67,647.059
Receivables Turnover 12.268
Total Asset Turnover 1.211

CL Liquidity

Current Ratio 1.113
Quick Ratio 0.706
Cash Ratio 0.242

CL Profitability

Gross Margin 57.825
Operating Margin 21.231
Pretax Margin 17.433
Net Margin 11.821
Return on Assets 14.32
Return on Equity 455.446
Return on Total Capital 23.778
Return on Invested Capital 24.485

CL Capital Structure

Total Debt to Total Equity 1,488.342
Total Debt to Total Capital 93.704
Total Debt to Total Assets 55.292
Long-Term Debt to Equity 1,418.555
Long-Term Debt to Total Capital 89.31
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Colgate-palmolive Co. - CL

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
16.47B 17.42B 17.97B 19.46B
Sales Growth
+4.96% +5.77% +3.13% +8.29%
Cost of Goods Sold (COGS) incl D&A
6.54B 7.13B 7.82B 8.21B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
539.00M 556.00M 545.00M 567.00M
Depreciation
451.00M 467.00M 465.00M 495.00M
Amortization of Intangibles
88.00M 89.00M 80.00M 72.00M
COGS Growth
+1.90% +9.02% +9.67% +4.98%
Gross Income
9.93B 10.29B 10.15B 11.25B
Gross Income Growth
+7.07% +3.62% -1.39% +10.85%
Gross Profit Margin
+60.31% +59.08% +56.49% +57.82%
2020 2021 2022 2023 5-year trend
SG&A Expense
6.02B 6.41B 6.57B 7.12B
Research & Development
290.00M 307.00M 320.00M 343.00M
Other SG&A
5.73B 6.10B 6.25B 6.78B
SGA Growth
+9.19% +6.39% +2.47% +8.45%
Other Operating Expense
- - - -
-
Unusual Expense
13.00M 630.00M 830.00M 328.00M
EBIT after Unusual Expense
3.90B 3.26B 2.75B 3.80B
Non Operating Income/Expense
(91.00M) (52.00M) 72.00M (124.00M)
Non-Operating Interest Income
19.00M 17.00M 14.00M 55.00M
Equity in Earnings of Affiliates
12.00M 12.00M 12.00M 17.00M
Interest Expense
160.00M 117.00M 167.00M 287.00M
Interest Expense Growth
-16.67% -26.88% +42.74% +71.86%
Gross Interest Expense
161.00M 120.00M 172.00M 299.00M
Interest Capitalized
1.00M 3.00M 5.00M 12.00M
Pretax Income
3.65B 3.09B 2.66B 3.39B
Pretax Income Growth
+10.48% -15.36% -13.83% +27.52%
Pretax Margin
+22.14% +17.72% +14.80% +17.43%
Income Tax
787.00M 749.00M 693.00M 937.00M
Income Tax - Current - Domestic
259.00M 228.00M 199.00M 72.00M
Income Tax - Current - Foreign
528.00M 521.00M 494.00M 865.00M
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
12.00M 12.00M 12.00M 17.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.86B 2.34B 1.97B 2.46B
Minority Interest Expense
165.00M 172.00M 182.00M 155.00M
Net Income
2.69B 2.17B 1.78B 2.30B
Net Income Growth
+13.86% -19.63% -17.59% +28.85%
Net Margin Growth
+16.36% +12.43% +9.93% +11.82%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.69B 2.17B 1.78B 2.30B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.69B 2.17B 1.78B 2.30B
EPS (Basic)
3.1454 2.5633 2.1342 2.7798
EPS (Basic) Growth
+14.16% -18.51% -16.74% +30.25%
Basic Shares Outstanding
856.80M 845.00M 836.40M 827.40M
EPS (Diluted)
3.1363 2.5533 2.128 2.7738
EPS (Diluted) Growth
+14.10% -18.59% -16.66% +30.35%
Diluted Shares Outstanding
859.30M 848.30M 838.80M 829.20M
EBITDA
4.45B 4.44B 4.13B 4.70B
EBITDA Growth
+3.95% -0.18% -7.02% +13.75%
EBITDA Margin
+27.02% +25.50% +22.99% +24.15%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 107.15
Number of Ratings 25 Current Quarters Estimate 0.901
FY Report Date 12 / 2024 Current Year's Estimate 3.584
Last Quarter’s Earnings 0.91 Median PE on CY Estimate N/A
Year Ago Earnings 3.23 Next Fiscal Year Estimate 3.872
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 18 16 21 21
Mean Estimate 0.90 0.93 3.58 3.87
High Estimates 0.92 0.97 3.61 4.00
Low Estimate 0.88 0.91 3.50 3.77
Coefficient of Variance 1.32 2.10 0.66 1.40

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 13
OVERWEIGHT 1 1 1
HOLD 9 9 10
UNDERWEIGHT 2 1 1
SELL 1 1 0
MEAN Overweight Overweight Overweight

Insider Actions for Colgate-palmolive Co. - CL

Date Name Shares Transaction Value
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer 82,136 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $77.04 per share 6,327,757.44
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer 36,726 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $94.11 per share 3,456,283.86
Nov 8, 2024 Stanley J. Sutula Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 4, 2024 Brian O. Newman Director 2,184 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.24 per share 229,844.16
Oct 4, 2024 John P. Bilbrey Director 32,879 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.24 per share 3,460,185.96
Oct 4, 2024 Lisa M. Edwards Director 14,012 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.24 per share 1,474,622.88
Oct 4, 2024 Lorrie M. Norrington Director 35,083 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $105.24 per share 3,692,134.92
Sep 13, 2024 Gregory Malcolm EVP and Controller 9,974 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $106.84 per share 1,065,622.16
Aug 9, 2024 John W. Kooyman Chief of Staff 3,191 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $102.88 per share 328,290.08
Aug 9, 2024 Gregory Malcolm EVP and Controller N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 9, 2024 John W. Kooyman Chief of Staff 27,972 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $72.29 per share 2,022,095.88
Aug 9, 2024 Gregory Malcolm EVP and Controller 10,377 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $103.1 per share 1,069,868.70
Aug 9, 2024 John W. Kooyman Chief of Staff N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 9, 2024 Sally Massey Chief Human Resources Officer 29,792 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $76.41 per share 2,276,406.72
Aug 9, 2024 Sally Massey Chief Human Resources Officer 13,942 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $103.28 per share 1,439,929.76
Aug 9, 2024 Sally Massey Chief Human Resources Officer 15,851 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Jennifer M. Daniels CLO and Secretary 81,948 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $72.29 per share 5,924,020.92
May 17, 2024 Jennifer M. Daniels CLO and Secretary 59,698 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $94.15 per share 5,620,566.70
May 17, 2024 Jennifer M. Daniels CLO and Secretary 44,000 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 16, 2024 Martina T. Hund-Mejean Director 2,201 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Colgate-Palmolive Co. in the News